Американское общество гирудотерапии

Restless Leg Syndrome (Investigational)

Investigational adjunct for primary RLS refractory to dopamine agonists; very limited anecdotal evidence; iron status and conventional therapy should be optimized first.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for restless leg syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for RLS is investigational.
Какие доказательства существуют?
Tier C (investigational). Only small case reports of subjective improvement; there are no randomized controlled trials. Evidence-based RLS care per AAN 2016 guidelines starts with iron status optimization (target ferritin above 75 ng/mL, transferrin saturation above 20 percent), avoidance of provoking medications (most antihistamines, many antidepressants, dopamine antagonists), and pharmacotherapy with alpha-2-delta ligands (gabapentin enacarbil, pregabalin) or, with caution about long-term augmentation, dopamine agonists.
Основные риски
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the calves for 5 to 10 days
  • Temporary worsening of RLS symptoms for 1 to 3 nights
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Small permanent scars at bite sites
  • Delay or replacement of evidence-based iron repletion and pharmacotherapy
Кому не следует это рассматривать
  • Patients with secondary RLS from end-stage renal disease, pregnancy, or iron deficiency without first addressing the cause
  • Patients experiencing augmentation from dopamine agonists (require medication review first)
  • Patients on anticoagulants or who have hemophilia or other bleeding disorders
  • Patients with severe anemia (Hb under 10 g/dL) or active infection
  • Patients with active peripheral neuropathy or vascular insufficiency
  • Patients who have not tried iron repletion or first-line medications
О чём спросить врача
  • Has my ferritin been tested, and is it above 75 ng/mL? Have I had a trial of iron supplementation?
  • What is my International Restless Leg Syndrome Study Group score?
  • Have I been screened for medications or substances that worsen RLS (some antidepressants, antihistamines, neuroleptics, caffeine, alcohol)?
  • Have I tried alpha-2-delta ligands (gabapentin enacarbil or pregabalin)?
  • If I am on a dopamine agonist, am I experiencing augmentation, and is rotation appropriate?
  • What evidence supports leech therapy for RLS specifically?
  • What is the practitioner's experience and Aeromonas-prevention plan?
Когда срочно обратиться за медицинской помощью
  • New severe leg weakness, numbness, or loss of bladder/bowel control (cauda equina — call 911)
  • Sudden severe leg pain, pallor, or coldness (acute limb ischemia)
  • New unilateral leg swelling, redness, and pain (possible DVT)
  • Spreading redness, warmth, pus, or red streaks at a bite site
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

Что это НЕ означает

  • This is not FDA-cleared for restless leg syndrome.
  • Case reports of subjective improvement do NOT establish efficacy versus iron repletion or proven medications.
  • Mechanism rationale (local vasodilation) does NOT address the dopaminergic / iron-related pathophysiology of RLS.
  • Leech therapy is not a substitute for iron repletion or evidence-based pharmacotherapy.
  • Augmentation from dopamine agonists requires medical management, not complementary therapy.

Перекрёстные ссылки безопасности

Clinical Profile

Category
neurological
ICD-10
G25.81
Safety tier
medium

Evidence Summary

Restless leg syndrome (Willis-Ekbom disease) management per AAN 2016 guidelines focuses on iron repletion (ferritin >75 ng/mL), avoidance of provoking medications, and pharmacotherapy with alpha-2-delta ligands (gabapentin enacarbil) or dopamine agonists (with augmentation risk). No controlled clinical trial of leech therapy for restless leg syndrome has been published, and the intervention is not part of any evidence-based treatment pathway. RLS pathophysiology (dopaminergic signaling and iron dysregulation) is not addressed by hirudin, calin, or other leech salivary components, so any use would be purely investigational and mechanistically unsupported.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Wollina U et al. (2007)0

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Active deep vein thrombosis (acute phase <2 weeks)
  • Critical limb ischemia (ABI <0.4)
  • Secondary RLS from uremia or pregnancy (treat primary cause)
  • Augmentation from dopamine agonist (require medication review first)
  • Concurrent peripheral neuropathy mimicking RLS

Related ASH Compounds

Leech-derived molecules implicated in this condition, each profiled in the ASH compound registry:

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Restless Leg Syndrome (Investigational) — Hirudotherapy Evidence | ASH